Navigation Links
Study Asks: Are Physicians Overusing an Invasive Cardiac Treatment?
Date:12/11/2008

PORTLAND, Maine, Dec. 11 /PRNewswire/ -- Researchers are asking if cardiology patients receive intervention-type treatments, such as stents, too often and too quickly.

In regions of the country where cardiologists perform high numbers of cardiac catheterizations to diagnose heart problems, patients may be receiving a treatment known as percutaneous cardiac intervention (PCI) more than they need or want, according to a study published online this week in the journal Circulation. The study will also be in the journal's December 16/23 print edition.

In the study, Maine Medical Center researchers analyzed the relationship between cardiac catheterizations and the two most common invasive cardiac treatments used to restore blood flow -- PCI and coronary artery bypass graft (CABG) surgery. They found a very high correlation between cardiac catheterization rates and PCI rates; researchers noted a much weaker connection between cardiac catheterization and the number of CABGs.

"Several recent studies on managing heart disease have touted the benefits of treatment with medication and lifestyle changes -- as opposed to invasive treatment, says Lee Lucas, PhD, principal investigator at the Maine Medical Center Research Institute. "The results from our study reflect what might be a tendency for physicians to opt for treating invasively rather than conservatively if they see anything unusual during the diagnostic process."

"Our research indicates that patients may be getting PCIs that aren't necessary," says Dr. Lucas. She says that her findings might reflect the fact that criteria for PCIs are not as clearly defined as those for CABG.

"In addition, performing the diagnostic test and treatment in the same procedure, which is common practice, results in a situation in which patients have little opportunity to share in the decision making process before a
'/>"/>

SOURCE Maine Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Study Questions Value of Anti-Meth Campaign
2. U.S. Department of Education Funded Study Demonstrates, WordWorld, a PBS KIDS(R) Television Series Works as Critical Early Literacy Tool
3. Success of anti-meth ads questioned by study
4. Study first to show that RNA interference can facilitate vaccine development
5. Study Suggests Sugar May Be Addictive
6. UC San Diego scientists developing brain imaging methods for studying natural human behavior
7. Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
8. Study finds selenium, vitamin E do not prevent prostate cancer
9. Study Finds Doctors Use of E-Prescribing Systems Linked to Formulary Data Can Boost Drug Cost Savings
10. Genetic Markers Identified for Alcohol Response in UCSF Gallo Study
11. University of Michigan, Blue Care Network Study Quantifies Health Care Savings of Regular Dental Care for Patients with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... (PRWEB) July 25, 2014 Merrill ... of technology-enabled services for the financial, legal, healthcare ... virtual data room business, Merrill DataSite, has been ... presented by GrowthBusiness at the M&A Awards 2014 ... the achievements of entrepreneurs, management teams, advisors and ...
(Date:7/25/2014)... Ticket Down is a reliable source for ... at California Memorial Stadium. With the post-World Cup emotions ... organizers of the 2014 Guinness International Champions Cup have brought ... With teams representing La Liga, English Premier League, Serie A, ... best football players from around the world to 12 American ...
(Date:7/25/2014)... July 25, 2014(BRONX, NY)A study involving nearly 27,000 older ... 10 met criteria for pre-dementia based on a simple ... they have cognitive complaints. People who tested positive for ... dementia within 12 years. The study, led by scientists ... Yeshiva University and Montefiore Medical Center , was ...
(Date:7/25/2014)... As thousands of transvaginal mesh lawsuits ... Liebhard LLP notes that the Food & Drug Administration ... group, Public Citizen, to order a global recall of ... 1, 2014, and released to the public last week, ... ban on the marketing of all surgical mesh devices ...
(Date:7/25/2014)... drug can protect vulnerable neurons and reduce motor ... researchers at Emory University School of Medicine have ... Journal of Parkinson,s Disease . , The ... reach the brain at sufficient levels and have ... an insulin shot. Previous studies of XPro1595 in ...
Breaking Medicine News(10 mins):Health News:Merrill DataSite Recognized as “Technology Provider of the Year” by GrowthBusiness at the M&A Awards 2014 Event 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 2Health News:Real Madrid vs. Inter Milan Tickets Berkeley: Ticket Down Slashes Ticket Prices on Guinness International Champions Cup Tickets at California Memorial Stadium 3Health News:Slow walking speed and memory complaints can predict dementia 2Health News:Slow walking speed and memory complaints can predict dementia 3Health News:Slow walking speed and memory complaints can predict dementia 4Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuit News: FDA Rejects Petition Seeking Ban and Global Recall of All Transvaginal Mesh Products, Bernstein Liebhard LLP Reports 4Health News:Anti-inflammatory drug can prevent neuron loss in Parkinson's model 2
... in just one state, but a resurgence could occur, CDC ... As the H1N1 swine flu outbreak eases to a point ... health officials are still urging Americans to get their swine ... Week," Kathleen Sebelius, Secretary of the U.S. Department of Health ...
... , , , , MINNEAPOLIS, Jan. ... National Courage Award . Since 1980, Minnesota-based Courage ... an individual,s contributions to the health, welfare and rehabilitation of ... winners include: Max Cleland, Justin Dart Jr., Sen. Bob Dole, ...
... DHA boosted memory of Alzheimer,s patients in study , ... nutrients might help improve memory in Alzheimer,s patients by stimulating ... shows. , Uridine, choline and the omega-3 fatty acid DHA ... molecules that make up brain cell membranes, which form synapses. ...
... LAVAL, QC, Jan. 8 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... draw down of $1 million under its standby equity distribution (SEDA) ... Labopharm issued 482,165 of its common shares to YA at a ... (All currency figures are in Canadian dollars.) , In accordance with ...
... ... at 32nd annual San Antonio Breast Cancer Symposium , ... Los Angeles, CA (PRWEB) January ... announced that multiple clinical studies of the chemotherapy agent ABRAXANE® for Injectable Suspension ...
... low level X-rays, , FRIDAY, Jan. 8 (HealthDay News) ... airline flight approaching Detroit, officials have announced plans to increase ... some travelers wondering about the health effects of these devices. ... expose passengers to excess levels of radiation? Experts say no. ...
Cached Medicine News:Health News:As Swine Flu Ebbs, Officials Stress Importance of Vaccine 2Health News:As Swine Flu Ebbs, Officials Stress Importance of Vaccine 3Health News:Courage Center Seeks Nominations for 2010 National Courage Award 2Health News:Labopharm settles $1 million draw down under standby equity distribution agreement 2Health News:Labopharm settles $1 million draw down under standby equity distribution agreement 3Health News:Abraxis Provides Overview Of ABRAXANE Study 2Health News:Abraxis Provides Overview Of ABRAXANE Study 3Health News:Airport Full Body Scanners Pose No Health Threat: Experts 2Health News:Airport Full Body Scanners Pose No Health Threat: Experts 3
(Date:7/24/2014)... HILDEN , Deutschland, und ... , ... ermöglicht QIAGEN die Entwicklung von ... Genpanels, für Blutkrebs  Neuer Test ... Patienten mit Knochenmarkserkrankungen (myelodysplastischen Syndromen) einen günstigen ...
(Date:7/24/2014)... Ohio, July 24, 2014  Mettler-Toledo International Inc. (NYSE: ... for 2014.  Provided below are the highlights: ... the quarter compared with the prior year. Reported sales ... , Net earnings per diluted share as reported ... quarter of 2013. Adjusted EPS was $2.57, an increase ...
(Date:7/24/2014)... 24, 2014 IGI Laboratories, Inc. (NYSE MKT: ... specialty generic pharmaceutical company, today announced it has accepted  ... Directors.  Mr. Finio has accepted a senior level finance ... of his acceptance of his new position, Mr. Finio ... Director for IGI Laboratories, Inc.  The effective date of ...
Breaking Medicine Technology:QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 2Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 3Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 4Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 5Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 6Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 7Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 8Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 9Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 10Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 11Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 12Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 13Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 14Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 15Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 16Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 17Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 18Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 19Volcano Reports 44 Percent Increase in Fourth Quarter Revenues 20Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 2Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 3Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 4Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 5Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 6Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 7Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy 8
... with a single lumen or dual lumen ... adapter., ,Trac-Wedge™ device, and patient label ... patient label. Dual swivel elbow kits do ... Steri-Cath® systems are latex-free. , ...
... Minimize Patient Trauma and Increase Staff Protection ... (10 Fr, 12 Fr, 14 Fr, 16 ... Suction Catheters with Contro-Vac Valves and DeLee ... potential for inflammation,during suctioning. Each catheter utilizes ...
Suction Catheter Mini Soft Kits without Solutions...
SAFE-T-VAC Suction Catheter Kits with Protective Sleeve...
Medicine Products: